Connection

Alessandro Bartoloni to Biomarkers

Back to Details
This is a "connection" page, showing publications Alessandro Bartoloni has written about Biomarkers.
Alessandro Bartoloni
Connection Strength
0.020
Biomarkers
  1. Compassionate use of JAK1/2 inhibitor ruxolitinib for severe COVID-19: a prospective observational study. Leukemia. 2021 04; 35(4):1121-1133.
    View in: PubMed
    Score: 0.010
  2. Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary Study. J Allergy Clin Immunol Pract. 2020 Sep; 8(8):2575-2581.e2.
    View in: PubMed
    Score: 0.010
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.